These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26791842)

  • 21. [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].
    Heindl LM; Koch KR; Schlaak M; Mauch C; Cursiefen C
    Ophthalmologe; 2015 Nov; 112(11):907-11. PubMed ID: 26502167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological and morphological data of ocular melanocytic lesions.
    Baderca F; Solovan C; Boghian L
    Rom J Morphol Embryol; 2013; 54(1):77-83. PubMed ID: 23529312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
    Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
    Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjunctival melanoma: pitfalls and dilemmas in management.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2010 Sep; 21(5):380-6. PubMed ID: 20531189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uveal prolapse following cataract extraction simulating melanoma.
    Marr BP; Shields JA; Shields CL; Materin MA; Tuncer S
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):250-1. PubMed ID: 18556954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.
    Griewank KG; Murali R; Schilling B; Scholz S; Sucker A; Song M; Süsskind D; Grabellus F; Zimmer L; Hillen U; Steuhl KP; Schadendorf D; Westekemper H; Zeschnigk M
    Br J Cancer; 2013 Jul; 109(2):497-501. PubMed ID: 23799844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential diagnosis of conjunctival melanoma: exteriorized uveal melanoma].
    Meyer A; D'Hermies F; Morel X; Elmaleh C; Renard G
    J Fr Ophtalmol; 1997; 20(10):775-8. PubMed ID: 9587593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uveal melanoma: laboratory advances and new frontiers in patient care.
    Xu TT; Moser JC; Dalvin LA
    Curr Opin Ophthalmol; 2021 May; 32(3):301-308. PubMed ID: 33606406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
    Jiang K; Brownstein S; Lam K; Burns B; Farmer J
    JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjunctival Melanoma - Epidemiological Trends and Features.
    Kaštelan S; Gverović Antunica A; Beketić Orešković L; Salopek Rabatić J; Kasun B; Bakija I
    Pathol Oncol Res; 2018 Oct; 24(4):787-796. PubMed ID: 29802540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ocular melanomas : An update].
    Kalirai H; Müller PL; Jaehne D; Coupland SE
    Pathologe; 2017 Nov; 38(6):491-499. PubMed ID: 29038913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric metastases from conjunctival melanoma.
    Cohen VM; Ahmadi-lari S; Hungerford JL
    Melanoma Res; 2007 Aug; 17(4):255-6. PubMed ID: 17625457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetics of uveal melanoma: an emerging framework for targeted therapy.
    Harbour JW
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):171-81. PubMed ID: 22268848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options.
    Brouwer NJ; Verdijk RM; Heegaard S; Marinkovic M; Esmaeli B; Jager MJ
    Prog Retin Eye Res; 2022 Jan; 86():100971. PubMed ID: 34015548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of pigmented conjunctival lesions.
    Oellers P; Karp CL
    Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
    Goh AY; Layton CJ
    Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant melanoma of the uvea].
    Boaziz C; Mazeron JJ; Morere JF; Breau JL; Israël L
    Bull Cancer; 1993 Jul; 80(7):577-83. PubMed ID: 8204938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.